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Introduction. Image-guided radiotherapy (IGRT) increases the accuracy of treatment. Daily alignment using ﬁducial markers is an
effective method of localizing prostate displacement. It provides the option of reducing margins, thus limiting normal tissue
toxicity and allowing the possibility of dose escalation for better long-term control.
Objective. Evaluate the acute genitourinary and gastrointestinal toxicity in prostate cancer patients treated with 3-dimensional
conformal radiotherapy (3D-CRT) and IGRT using ﬁducial markers.
Method. Between 2008 and 2012, 170 prostate cancer patients were treated with 3D-CRT using daily portal imaging of ﬁducial
markers. 137 patients received 76Gy in 38 fractions, 27 had 78Gy in 39 fractions. 116 patients had hormonal treatment. 20 patients
had pelvic radiotherapy-irradiation. The acute toxicity was evaluated retrospectively according to Common Terminology Criteria
Adverse Events V3.0. Analysis was conducted for the maximum grade of toxicity. Statistical comparison was performed using
the Student t test.
Results. Grade 3 acute genitourinary toxicity was unusual (1.76%). There was no severe grade 3–4 acute gastrointestinal toxicity.
Grade 2 acute genitourinary toxicity affected 24.70%of patients. Grade 2 acute gastrointestinal toxicity affected 17.05%of patients.
On Univariate analysis grade 2 acute genitourinary toxicity was higher for the pelvic irradiation and hormonal treatment was
p<0.05. There was no signiﬁcant statistical differences for acute toxicity between 78Gy in 39 fractions group and 76Gy in 38
fractions.
Conclusions. 3D-RTC with IGRT is feasible and is well tolerated with acceptable acute toxicity. Our results are comparable with
other techniques such as IMRT, Tomotherapy and IG Arc therapy. IGRT using ﬁducial markers is one method which may possibly
reduce toxicity whilst maintaining dose escalation.
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Purpose. To evaluate our results in low dose rate brachytherapy with I125 seeds only or with 3D conformal radiotherapy (RT) in
local prostate cancer.
Material and methods. From October 2005 till February 2008, 157 patients treated with I 125 loose seeds and auto load technique
have been evaluated. They were diagnosed and staged by ultrasound guided biopsy, being the main stage T1c. Staging was not
performed by image with MRI. The median PSA before the treatment was 7.3ng/ml (range 4.11–17.41). Gleason 6 was detected in
96 patients (67.13%), Gleason 5 in 11 patients (7.69%) and Gleason 7 was detected in 36 patients (25.17%). 31 (19.75%) patients had
bilateral involvement of the prostate, 106 (80.25%) patients had unilateral affection and in 20 it was not possible to determine.
Low dose rate brachytherapy with I125 seeds only was performed in 123 patients (78.34%) D90 145Gy and in 32 patients (21.62%)
D90 105Gy RT was added (46Gy/23 fr).
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